Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting125%
enrolling_by_invitation125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
completed

Long-term Atogepant in Real-world Practice

NCT07699549
recruitingnot_applicable

BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache

NCT07136740
enrolling_by_invitationnot_applicable

Headache Diary for Migraine Patients

NCT07698249
completednot_applicable

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

NCT04341298

Clinical Trials (4)

Showing 4 of 4 trials
NCT07699549

Long-term Atogepant in Real-world Practice

Completed
NCT07136740Not Applicable

BioTenCer: Biofeedback as Preventive Treatment in Tension Type Headache

Recruiting
NCT07698249Not Applicable

Headache Diary for Migraine Patients

Enrolling By Invitation
NCT04341298Not Applicable

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4